Blood transfusions can be made safe by decreasing reactive immune responses caused by frequent transfusions. This is very helpful in patients who have thalassemia or sickle cell disease and those who require regular blood transfusions. Immune responses can be decreased by CRISPR-Cas9 gene editing tool. The finding of this study is published in the Journal of EMBO Molecular Medicine.
While most people can safely receive a blood transfusion from donated blood, patients with blood disorders such as thalassemia or sickle cell disease require frequent transfusions. With repeated transfusion, patients eventually develop an immune response to all but the most specifically matched donor blood due to incompatibility at the level of minor blood group antigens.
Prehospital Blood Transfusion Linked With Improved Survival
Blood product transfusion within minutes of injury or prior to hospitalization is associated with greater survival than delayed or no transfusion.
Advertisement
‘CRISPR-Cas9 gene editing tool can be used in combination with laboratory culture of red blood cells to produce rare or customized red blood cells for patients with specific needs.
’
Tweet it Now
Using CRISPR-Cas9 mediated gene editing, the team of scientists based at the NIHR Blood and Transplant Research Unit (NIHR BTRU) in red cell products, BrisSynBio Centre and NHS Blood and Transplant in Bristol created individual cell lines in which specific blood group genes were altered to prevent the expression of blood group proteins that can cause immune reactions.
Building on this gene-editing approach, the team then went on to produce cells that combined the deletion of multiple blood groups in a single cell line that could be differentiated to generate functional novel red blood cells with extremely broad transfusion compatibility. Transfusions of red blood cells edited to improve compatibility could provide better treatments for those patients whose clinical needs are difficult to meet.
![Blood Transfusion From Previously Pregnant Donor Increases Mortality Risk]( "Blood Transfusion From Previously Pregnant Donor Increases Mortality Risk")
Transfusion-related acute lung injury occurs mainly due to transfusions from female donors with a history of pregnancy and can cause death.
This study, published this week in the prestigious EMBO Molecular Medicine journal provides the first proof of principle demonstration that gene editing can be used in combination with laboratory culture of red blood cells to generate rare or customized red blood cells for patients with specific needs. While the authors are keen to stress the many challenging technical obstacles that must be overcome before this approach could be translated to a clinical product, the work does provide an exciting window into the possible applications of red blood cells produced from gene edited cell lines.
Dr. Ashley Toye Director of the Bristol NIHR BTRU said: "Blood made using genetically edited cells could one day provide compatible transfusions for a group of patients for whom blood matching is difficult or impossible to achieve within the donor population. However, much more work will still be needed to produce blood cells suitable for patient use."
Source: Eurekalert
Blood Transfusion From Previously Pregnant Donor Increases Mortality Risk
Transfusion-related acute lung injury occurs mainly due to transfusions from female donors with a history of pregnancy and can cause death.
Advertisement
This study, published this week in the prestigious EMBO Molecular Medicine journal provides the first proof of principle demonstration that gene editing can be used in combination with laboratory culture of red blood cells to generate rare or customized red blood cells for patients with specific needs. While the authors are keen to stress the many challenging technical obstacles that must be overcome before this approach could be translated to a clinical product, the work does provide an exciting window into the possible applications of red blood cells produced from gene edited cell lines.
Dr. Ashley Toye Director of the Bristol NIHR BTRU said: "Blood made using genetically edited cells could one day provide compatible transfusions for a group of patients for whom blood matching is difficult or impossible to achieve within the donor population. However, much more work will still be needed to produce blood cells suitable for patient use."
Source: Eurekalert
Reports Investigated 10 Percent Increase In The Number Of HIV Cases Through Blood Transfusion
One out of 100 HIV patients are tested positive for the virus who were found to be contracting the virus through blood transfusion during illnesses.
Advertisement
 Nearly 2,000 Indians Contract HIV After Receiving Blood TransfusionsAccess to safe blood is limited, especially in rural areas, because of a lack of proper screening devices, reveals the National AIDS Control Organisation (NACO) website. | Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News
Groundbreaking gene therapy for genetic beta thalassemia is now accessible as a treatment to a patient post-FDA approval.
Thymic stem cells actively participate in their environment by generating extracellular matrix proteins, essentially forming their own support system.
Scientists aspire to utilize stem cell transplantation for pediatric patients grappling with blood-related conditions like aplastic anemia, and thalassemia.
Researchers have sequenced male Y chromosomes, yielding a comprehensive blueprint of the entire human chromosome collection.
CALEC (Cultivated autologous limbal epithelial cells) procedure for stem cell transplant in eye procedures is safe and feasible, showing improved corneal surfaces or vision.
